Literature DB >> 28510760

What factors hinder the decision-making process for women with cancer and contemplating fertility preservation treatment?

Georgina Jones1, Jane Hughes1, Neda Mahmoodi1, Emily Smith2, Jonathan Skull3, William Ledger4.   

Abstract

BACKGROUND: Although fertility preservation (FP) treatment options have increased, the existing evidence suggests that many women with cancer do not feel well supported in making these decisions, but find them stressful and complex and fail to take up fertility care at this crucial time. Whilst existing reviews have all made important contributions to our understanding of the FP decision-making process, none of them examine solely and specifically these processes for women of reproductive age with a diagnosis of any cancer, leaving a gap in the knowledge base. Given the expectation that care is patient-centred, our review aims to address this gap which may be of help to those managing patients struggling to make difficult decisions in the often brief period before potentially sterilizing cancer treatment is started. OBJECTIVE AND RATIONALE: Underpinning this narrative review was the question 'What factors hinder the decision-making process for women with any cancer and contemplating FP treatment?' Our objectives were to (i) assess and summarize this existing literature, (ii) identify the factors that hinder this decision-making process, (iii) explore to what extent these factors may differ for women choosing different methods of FP and (iv) make recommendations for service delivery and future research. SEARCH
METHODS: A systematic search of the medical and social science literature from the 1 January 2005 up to the end of January 2016 was carried out using three electronic databases (Web of Science (PubMed), Ovid SP Medline and CINAHL via Ebsco). Included in the review were quantitative, qualitative and mixed-method studies. Reference lists of relevant papers were also hand searched. From the 983 papers identified, 46 papers were included. Quality assessment was undertaken using the Mixed Methods Appraisal Tool and thematic analysis was used to analyse the data. OUTCOMES: From the analysis, 6 key themes with 15 sub-themes emerged: (i) fertility information provision (lack of information, timing of the information, patient-provider communication); (ii) fear concerning the perceived risks associated with pursuing FP (delaying cancer treatment, aggravating a hormone positive cancer and consequences of a future pregnancy); (iii) non-referral from oncology (personal situation, having a hormone positive cancer, FP not a priority and transition between service issues); (iv) the dilemma (in survival mode, whether to prioritize one treatment over another); (v) personal situation (parity, relationship status) and (iv) costs (financial concerns). WIDER IMPLICATIONS: This review has found that a wide range of internal and external factors impact the FP decision-making process. Key external issues related to current service delivery such as the provision and timing of FP information, and lack of referral from oncology to the fertility clinic. However, internal issues such as women's fears concerning the perceived risks associated with pursuing FP also hindered decision-making but these 'risks' were typically overestimated and non-evidence based. These findings suggest that the implementation of a range of decision support interventions may be of benefit within the clinical care pathway of FP and cancer. Women would benefit from the provision of more evidence-based FP information, ideally received at cancer diagnosis, in advance of seeing a fertility specialist, for example through the implementation of patient decision aids. Healthcare professionals in both oncology and fertility services may also benefit from the implementation of training programmes and educational tools targeted at improving the communication skills needed to improve collaborative decision-making and deliver care that is patient-centred. Exploration of the current barriers, both intellectual and practical, that prevent some patients from accepting FP will help care providers to do better for their patients in the future. Finally, the extent to which a poorer prognosis and moral, ethical and religious beliefs influence the FP decision-making process also warrant further research.
© The Author 2017. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oup.com

Entities:  

Keywords:  cancer; decision-making; females; fertility preservation; narrative review; oncofertility

Mesh:

Year:  2017        PMID: 28510760     DOI: 10.1093/humupd/dmx009

Source DB:  PubMed          Journal:  Hum Reprod Update        ISSN: 1355-4786            Impact factor:   15.610


  22 in total

Review 1.  Fertility preservation in breast cancer with case-based examples for guidance.

Authors:  Mary E Hampe; Alice S Rhoton-Vlasak
Journal:  J Assist Reprod Genet       Date:  2020-02-01       Impact factor: 3.412

Review 2.  Development of a Pediatric Fertility Preservation Program: A Report From the Pediatric Initiative Network of the Oncofertility Consortium.

Authors:  Molly B Moravek; Leslie C Appiah; Antoinette Anazodo; Karen C Burns; Veronica Gomez-Lobo; Holly R Hoefgen; Olivia Jaworek Frias; Monica M Laronda; Jennifer Levine; Lillian R Meacham; Mary Ellen Pavone; Gwendolyn P Quinn; Erin E Rowell; Andrew C Strine; Teresa K Woodruff; Leena Nahata
Journal:  J Adolesc Health       Date:  2019-01-14       Impact factor: 5.012

3.  Factors Affecting Fertility Decision-Making Among Transgender Adolescents and Young Adults.

Authors:  Diane Chen; Moira A Kyweluk; Afiya Sajwani; Elisa J Gordon; Emilie K Johnson; Courtney A Finlayson; Teresa K Woodruff
Journal:  LGBT Health       Date:  2019-04       Impact factor: 4.151

4.  Fertility-related experiences after breast cancer diagnosis in the Sister and Two Sister Studies.

Authors:  Leah Hawkins Bressler; Jennifer E Mersereau; Chelsea Anderson; Juan L Rodriguez; M Elizabeth Hodgson; Clarice R Weinberg; Dale P Sandler; Hazel B Nichols
Journal:  Cancer       Date:  2019-04-23       Impact factor: 6.860

5.  Cancer, Fertility and Me: Developing and Testing a Novel Fertility Preservation Patient Decision Aid to Support Women at Risk of Losing Their Fertility Because of Cancer Treatment.

Authors:  Georgina L Jones; Rachael H Moss; Frances Darby; Neda Mahmoodi; Bob Phillips; Jane Hughes; Katharina S Vogt; Diana M Greenfield; Grete Brauten-Smith; Jacqui Gath; Tonia Campbell; Daniel Stark; Galina Velikova; John A Snowden; Ellissa Baskind; Mariano Mascerenhas; Daniel Yeomanson; Jonathan Skull; Sheila Lane; Hilary L Bekker; Richard A Anderson
Journal:  Front Oncol       Date:  2022-06-30       Impact factor: 5.738

6.  Oncofertility programs still suffer from insufficient resources in limited settings.

Authors:  Giuliano Bedoschi; Paula Andrea Navarro
Journal:  J Assist Reprod Genet       Date:  2022-03-08       Impact factor: 3.357

7.  An assessment of oncofertility content on reproductive endocrinology and infertility clinic websites.

Authors:  Vaidehi Mujumdar; Kavya Shivashankar; Rachel Madding; Ariel T Levy; Sushmita Gordhandas; Norman G Rosenblum; Scott Richard; Brent Monseur
Journal:  J Assist Reprod Genet       Date:  2022-02-25       Impact factor: 3.357

8.  Creation and evaluation of a cancer survivorship curriculum for pediatric resident physicians.

Authors:  Lindsay F Schwartz; Clarence H Braddock; Roy L Kao; Myung-Shin Sim; Jacqueline N Casillas
Journal:  J Cancer Surviv       Date:  2018-06-25       Impact factor: 4.442

9.  Impact of fertility concerns on endocrine therapy decisions in young breast cancer survivors.

Authors:  Tal Sella; Philip D Poorvu; Kathryn J Ruddy; Shari I Gelber; Rulla M Tamimi; Jeffrey M Peppercorn; Lidia Schapira; Virginia F Borges; Steven E Come; Ann H Partridge; Shoshana M Rosenberg
Journal:  Cancer       Date:  2021-04-22       Impact factor: 6.921

10.  And When I Die: Theory of Planned Behavior as Applied to Sperm Cryopreservation.

Authors:  Limor Dina Gonen
Journal:  Healthcare (Basel)       Date:  2021-05-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.